Pure Ductal carcinoma in situ (DCIS) of the man is extremely rare. The incidence is approximately 1% of all malignancies in men and 5% to 7% of male breast cancer (1). It is usually associated with invasive carcinoma. We reported three cases on DCIS in men. The aim of our study is to further emphasize the importance of this disease for men and to evaluate the management of this rare tumor.
Case PresentationsCase 1 A 58-year old man consulted for a left breast mass that has been evolving for 3 months. There was no remarkable personal history or family history of breast's disease. He had a remarkable history of smoking with 38 packages per year. On physical examination, we found a mobile, well-defined mass, measuring 20 mm × 20 mm without axillary lymph node. The right breast was unremarkable. Mammography and ultrasound showed a circumscribed nodule without calcifications in the left breast. This was considered as ACR 3 of the classification of the American College of Radiology (ACR) (Figure 1). We performed a core needle biopsy. The histological findings showed a DCIS. The patient underwent a mastectomy with sentinel node. Macroscopically, the tumor was greyish to white and measured 17 mm in its greater axis. The definitive histopathological assessments showed DCIS with papillary and cribriform patterns (Figure 2). The nuclear grade was intermediate, and there was no necrosis. Cells were polarized. The margins were free, with a clearance of 15 mm. No invasive cancer was present. The nuclear grade was I of Van Nuys. Van Nuys Prognostic Index score (VNPI) was 6 (Table 1). Sentinel lymph node sampling brought back three lymph nodes which were all negative. The immunohistochemical examination of estrogen (ER) and progesterone (PR) receptors were negative for both. The patient was noted to be doing well until now, and he is regularly followed up, with a total duration of follow-up of 10 years.A written informed consent was obtained from the patient.